Companies
Top talent, not low tax, driving Bristol Myers Squibb’s Irish investment, executive says
Pharmaceutical giant is hiring 350 new staff in Ireland as part of $400m injection which will make Dublin office more central to global operations
An senior Irish executive at Bristol Myers Squibb has insisted that access to talented workers, and not Ireland’s low-tax regime, is the reason the US pharma giant has invested so heavily in the country.
Pádraig Keane, vice-president of Bristol Myers Squibb’s biologics facility in north Dublin, said the drugmaker’s investment “goes beyond tax efficiency” after it announced a $400 million expansion of its Cruiserath campus.
Bristol Myers plans to create 350 jobs and build a ...
